Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial

Journal of Asthma

Volumn 44, Issue 8, 2007, Pages 605-608

  Eden, E ^a   Holbrook, J T ^b   Brantly, M L ^c   Turino, G M ^a   Wise, R A ^d,e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^e American Lung Association   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Asthma; Genetic screening

Indexed keywords

ALPHA 1 ANTITRYPSIN; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHODILATATION; ENZYME BLOOD LEVEL; ENZYME DEFECT; FEMALE; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; INFORMED CONSENT; LOW DRUG DOSE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SCORING SYSTEM; SCREENING TEST; SEVERE PERSISTENT ASTHMA;

ACETATES; ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; QUINOLINES; STATISTICS, NONPARAMETRIC; THEOPHYLLINE; UNITED STATES;

EID: 35448959593     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701540028     Document Type: Article

References (21)

1. ATS/ERS Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:845.
2. 1- Antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59.
3. Eden E, Mitchell D, Mehlman B, Khouli H, Nejat M, Grieco MH, Turino GM. Atopy, asthma, and emphysema in patients with severe α-1-Antitrypsin deficiency. Am J Respir Crit Care Med 1997; 156:68-74.
4. Katz RM, Lieberman J, Siegal SC. Alpha-1 antitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. L Allergy Clin Immunol. 1976; 57:41-45.
5. Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest 1993; 103:812-815.
6. Hyde JS, Werner P, Kumar CM, Moore BS, et al. Protease inhibitor variants in children and young adults with chronic asthma. Ann Allergy 1979; 43:8-13.
7. Townley RG, Southard JG, Radford P, Hopp RJ, Bewtra AK, Ford L. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990; 98:594-599.
8. Gaillard MC, Kilroe-Smith TA, Nogueira C, Dunn D, Jenkins T, Fine B, Kallenbach J. Alpha 1-protease inhibitor on bronchial asthma; phenotypes and biochemical characteristics. Am Rev Respir Dis 1992; 145:1311-1315.
9. Schwartz RH, Van Ess JD, Johnstone DE, Dreyfuss EM, Abrishami MA, Chai H. Alpha 1-antitrypsin in childhood asthma. J Allergy Clin Immunol 1977; 59:31-34.
10. 1-antitrypsin deficiency. Eur Resp J 2000; 15:886-890.
11. 1 antitrypsin deficiency: spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991; 88:891-897.
12. 1-proteinase inhibitor and tissue kalikrein in controlling allergic ovine airway hyperresponsiveness. Am J Respir Crit Care Med 1996; 154:36-42.
13. Clinical Trial of Low-Dose Theophylline and Montelukast in patients with poorly controlled asthma. The American Lung Association Asthma Clinical Research Centers Writing Committee: Irvin CG, Kaminsky DA, Anthonisen NR, Castro M, Hanania NA, Holbrook JT, Lima JJ, Wise RA. Am J Respir Crit Care Med 2007; 175:235-242.
14. Juniper EF, Bousquet J, Abetz L, Bateman ED. The GOAL Committee. Identifying well controlled and not well controlled asthma using the Asthma Control Questionnaire. Respir Med 2006; 100:616-621.
15. 1-1 antitrypsin standard to establish ranges for the common normal and deficiency phenotypes. Chest 1991; 100:703-708.
16. SAS/STAT User's Guide Version 8.0. Cary, NC: SAS Institute, 1999.
17. Morse JO, Lebowitz MD, Knudson RJ, Burrows B. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. New Engl J Med 1977; 296:1190-1194.
18. Van Veen IH, ten Brinke A, van der Linden AC, Rabe KF, Bel EH. Deficient alpha-1 phenotypes and persistent airflow limitation in severe asthma. Respirat Med 2006; 9:1534-1539.
19. 1 antitrypsin deficiency masquerading as asthma. J Allergy 1970; 46:40-48.
20. Lindmark B, Svenonius E, Enksson S. Heterozygous alpha-1 chymotrypsin and PiZ alpha-1 antitrypsin deficiency. Prevalence and clinical spectrum in asthmatic children. Allergy 1990; 45:197-203.
21. 1-Antitrypsin as a risk for infant and adult respiratory outcomes in a national birth cohort. Amer J Respir Cell Mol Biol 2004; 31:559-564.